Clinical significance of disease‐specific MYD88 mutations in circulating DNA in primary central nervous system lymphoma

Recent sequencing studies demonstrated the MYD88 L265P mutation in more than 70% of primary central nervous system lymphomas (PCNSL), and the clinical significance of this mutation has been proposed as diagnostic and prognostic markers in PCNSL. In contrast, mutational analyses using cell‐free DNAs...

Descripción completa

Detalles Bibliográficos
Autores principales: Hattori, Keiichiro, Sakata‐Yanagimoto, Mamiko, Suehara, Yasuhito, Yokoyama, Yasuhisa, Kato, Takayasu, Kurita, Naoki, Nishikii, Hidekazu, Obara, Naoshi, Takano, Shingo, Ishikawa, Eiichi, Matsumura, Akira, Hasegawa, Yuichi, Chiba, Shigeru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765295/
https://www.ncbi.nlm.nih.gov/pubmed/29151258
http://dx.doi.org/10.1111/cas.13450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765295/
https://www.ncbi.nlm.nih.gov/pubmed/29151258
http://dx.doi.org/10.1111/cas.13450

Ejemplares similares